This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Nov 16;153(10):JC5-3.

doi: 10.7326/0003-4819-153-10-201011160-02003.

ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD

Affiliations

PMID: 21079210
DOI: 10.7326/0003-4819-153-10-201011160-02003

Comment

ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD

Chi-yuan Hsu. Ann Intern Med. 2010.

. 2010 Nov 16;153(10):JC5-3.

doi: 10.7326/0003-4819-153-10-201011160-02003.

Author

Affiliation

¹ University of California, San Francisco, San Francisco, California, USA.

PMID: 21079210
DOI: 10.7326/0003-4819-153-10-201011160-02003

No abstract available

PubMed Disclaimer

Comment on

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF. Palmer SC, et al. Ann Intern Med. 2010 Jul 6;153(1):23-33. doi: 10.7326/0003-4819-153-1-201007060-00252. Epub 2010 Jun 24. Ann Intern Med. 2010. PMID: 20439566 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon